152 related articles for article (PubMed ID: 21554679)
1. Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.
Perkins GD; Gates S; Lamb SE; McCabe C; Young D; Gao F
Trials; 2011 May; 12():113. PubMed ID: 21554679
[TBL] [Abstract][Full Text] [Related]
2. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
Gates S; Perkins GD; Lamb SE; Kelly C; Thickett DR; Young JD; McAuley DF; Snaith C; McCabe C; Hulme CT; Gao Smith F
Health Technol Assess; 2013 Sep; 17(38):v-vi, 1-87. PubMed ID: 24028755
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.
Gao Smith F; Perkins GD; Gates S; Young D; McAuley DF; Tunnicliffe W; Khan Z; Lamb SE;
Lancet; 2012 Jan; 379(9812):229-35. PubMed ID: 22166903
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
5. Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in acute lung injury to reduce pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial.
McAuley DF; Laffey JG; O'Kane CM; Cross M; Perkins GD; Murphy L; McNally C; Crealey G; Stevenson M; ;
Trials; 2012 Sep; 13():170. PubMed ID: 22985805
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
7. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial.
McAuley DF; Cross LM; Hamid U; Gardner E; Elborn JS; Cullen KM; Dushianthan A; Grocott MP; Matthay MA; O'Kane CM
Lancet Respir Med; 2017 Jun; 5(6):484-491. PubMed ID: 28526233
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
10. The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.
Perkins GD; Park D; Alderson D; Cooke MW; Gao F; Gates S; Lamb SE; Mistry D; Thickett DR
Trials; 2011 Mar; 12():79. PubMed ID: 21406094
[TBL] [Abstract][Full Text] [Related]
11. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
Muller M; Lefebvre F; Harlay ML; Glady L; Becker G; Muller C; Aberkane O; Tawk M; Julians M; Romoli A; Hecketsweiler S; Schneider F; Pottecher J; Chamaraux-Tran TN
Trials; 2021 Feb; 22(1):131. PubMed ID: 33573681
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study.
Lall R; Hamilton P; Young D; Hulme C; Hall P; Shah S; MacKenzie I; Tunnicliffe W; Rowan K; Cuthbertson B; McCabe C; Lamb S;
Health Technol Assess; 2015 Mar; 19(23):1-177, vii. PubMed ID: 25800686
[TBL] [Abstract][Full Text] [Related]
13. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
[TBL] [Abstract][Full Text] [Related]
14. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
[TBL] [Abstract][Full Text] [Related]
15. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.
Perkins GD; McAuley DF; Thickett DR; Gao F
Am J Respir Crit Care Med; 2006 Feb; 173(3):281-7. PubMed ID: 16254268
[TBL] [Abstract][Full Text] [Related]
16. Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial.
van der Hoeven SM; Binnekade JM; de Borgie CA; Bosch FH; Endeman H; Horn J; Juffermans NP; van der Meer NJ; Merkus MP; Moeniralam HS; van Silfhout B; Slabbekoorn M; Stilma W; Wijnhoven JW; Schultz MJ; Paulus F
Trials; 2015 Sep; 16():389. PubMed ID: 26329352
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
[TBL] [Abstract][Full Text] [Related]
20. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
